Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Liabilities from Discontinued Operations (2022)

Historic Liabilities from Discontinued Operations for Bioventus (BVS) over the last 1 years, with Q4 2022 value amounting to $228.9 million.

  • Bioventus' Liabilities from Discontinued Operations changed N/A to $228.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $228.9 million, marking a year-over-year change of. This contributed to the annual value of $228.9 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Bioventus reported Liabilities from Discontinued Operations of $228.9 million as of Q4 2022.
  • In the past 5 years, Bioventus' Liabilities from Discontinued Operations registered a high of $228.9 million during Q4 2022, and its lowest value of $228.9 million during Q4 2022.